Detalhe da pesquisa
1.
Emergence of an early SARS-CoV-2 epidemic in the United States.
Cell
; 184(19): 4939-4952.e15, 2021 09 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34508652
2.
Immunogenicity of a 2-Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial.
J Infect Dis
; 228(12): 1662-1666, 2023 12 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37561027
3.
Immunogenicity of the BA.1 and BA.4/BA.5 Severe Acute Respiratory Syndrome Coronavirus 2 Bivalent Boosts: Preliminary Results From the COVAIL Randomized Clinical Trial.
Clin Infect Dis
; 77(4): 560-564, 2023 08 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37036397
4.
Impact of Zika virus on the human type I interferon osteoimmune response.
Cytokine
; 137: 155342, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33130337
5.
MicroRNA 130a Regulates both Hepatitis C Virus and Hepatitis B Virus Replication through a Central Metabolic Pathway.
J Virol
; 92(7)2018 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29321333
6.
Exposure to human immunodeficiency virus/hepatitis C virus in hepatic and stellate cell lines reveals cooperative profibrotic transcriptional activation between viruses and cell types.
Hepatology
; 64(6): 1951-1968, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27531241
7.
EFTUD2 Is a Novel Innate Immune Regulator Restricting Hepatitis C Virus Infection through the RIG-I/MDA5 Pathway.
J Virol
; 89(13): 6608-18, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25878102
8.
The spliceosome factor SART1 exerts its anti-HCV action through mRNA splicing.
J Hepatol
; 62(5): 1024-32, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25481564
9.
Kinetic differences in the induction of interferon stimulated genes by interferon-α and interleukin 28B are altered by infection with hepatitis C virus.
Hepatology
; 59(4): 1250-61, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23913866
10.
Novel therapies for hepatitis C: insights from the structure of the virus.
Annu Rev Med
; 63: 373-87, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-21942423
11.
A genetic screen identifies interferon-α effector genes required to suppress hepatitis C virus replication.
Gastroenterology
; 144(7): 1438-49, 1449.e1-9, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23462180
12.
Real-world evidence of survival benefit of remdesivir: study of 419 propensity score-matched patients hospitalized over the alpha and delta waves of COVID-19 in New Orleans, LA.
Front Med (Lausanne)
; 11: 1390164, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38818394
13.
Rapid progression to decompensated cirrhosis, liver transplant, and death in HIV-infected men after primary hepatitis C virus infection.
Clin Infect Dis
; 56(7): 1038-43, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23264364
14.
The AMPK-related kinase SNARK regulates hepatitis C virus replication and pathogenesis through enhancement of TGF-ß signaling.
J Hepatol
; 59(5): 942-8, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23831117
15.
Dual activators of protein kinase R (PKR) and protein kinase R-like kinase PERK identify common and divergent catalytic targets.
Chembiochem
; 14(10): 1255-62, 2013 Jul 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-23784735
16.
Hepatitis C virus NS5A disrupts STAT1 phosphorylation and suppresses type I interferon signaling.
J Virol
; 86(16): 8581-91, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22674974
17.
Immunogenicity of the BA.1 and BA.4/BA.5 SARS-CoV-2 Bivalent Boosts: Preliminary Results from the COVAIL Randomized Clinical Trial.
medRxiv
; 2023 Mar 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37034641
18.
Immunogenicity of a Two Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial.
medRxiv
; 2023 Jun 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37333252
19.
Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial.
Nat Med
; 29(9): 2334-2346, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37640860
20.
A functional genomic screen reveals novel host genes that mediate interferon-alpha's effects against hepatitis C virus.
J Hepatol
; 56(2): 326-33, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21888876